Insight

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Photo from Triantafyllos Stylianopoulos/LinkedIn

Apr 9, 2024, 13:03

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Triantafyllos Stylianopoulos, Associate Professor at the University of Cyprus, Head of Cancer Biophysics Lab, made the following post on LinkedIn:

”Our new article in AACR Journals Clinical Cancer Research for the role of the mast cells in reprogramming the tumor micro-environment! Stabilizing their function with the anti-histamine ketotifen can improve immunotherapy in sarcomas. Early data from our ongoing clinical trial of ketotifen are presented!
This research was supported by the European Research Council (ERC).”

Read further.
Source: Triantafyllos Stylianopoulos/LinkedIn

AACR Journals Clinical Cancer Research cancer Cancer Biophysics Lab clinical trial ERC European Research Council immunotherapy ketotifen OncoDaily Oncology sarcoma Triantafyllos Stylianopoulos tumor micro-environment University of Cyprus

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen